Emphasizing the importance of a high level of awareness of immune checkpoint inhibitor (ICI)–associated cardiotoxicities among oncologists and cardiologists, this review article highlights the main aspects of ICI-related myocarditis and the benefits of a baseline CV evaluation for subsequent management.
Frontiers in Pharmacology